Godolphin had the first two in this a year ago and are likely to have the two, and possibly three, at the head of the market here. Really Special looked just that when easily landing the 1000 Guineas Trial over this trip but everything went wrong for her in the classic and she could only finish fifth. Back over this trip, she could prove that run all wrong though she'll need to be at her very best to see off the attentions of FLY AT DAWN. Three times a winner in the UK, he looked a natural on this surface when beating Cosmo Charlie in the 2000 Guineas Trial last month with the selection's stable companion Top Score, who enhanced the form by beating Nobelium on Turf subsequently, well behind in third. The latter was making a belated recourse debut and was only beaten a nose conceding 2lb so there's every chance of him reversing that form and reaching the frame. Grey Britain is held on that run though John Ryan's grey was having his first start since September so should get closer.
Really Special (8-9) 5th of 11, 4 1/4l behind Nashmiah (8-9) at Meydan 1m lst stks (1) fst in Feb.
Masham Star (IRE) (8-9) 6th of 12, 3 3/4l behind Top Score (8-9) at Meydan 7f stks gd in Feb.
Island Vision (IRE) (8-5) 7th of 12, 4 1/4l behind Top Score (8-9) at Meydan 7f stks gd in Feb.
Fly At Dawn (USA) 13-2 (8-8) won at Meydan 7f stks fst in Jan beating Cosmo Charlie (8-8) by 1l, 0 ran.
Silent Assassin (IRE) (9-0) last of 9, dist behind Thunder Snow (9-0) at Meydan 1m Grp 3 stks (1) fst in Feb.
Souls In The Wind (IRE) (8-5) 4th of 12, 3 1/2l behind Top Score (8-9) at Meydan 7f stks gd in Feb.
Top Score (8-9) won at Meydan 7f stks gd in Feb beating Nobelium (8-9) by ns, 12 ran.
Mufeed (USA) 40-1 (8-8) 9th of 0, 16 1/2l behind Fly At Dawn (8-8) at Meydan 7f stks fst in Jan.
Good Omen 25-1 (8-8) 12th of 0, 26 3/4l behind Fly At Dawn (8-8) at Meydan 7f stks fst in Jan.
Nobelium (USA) (8-9) 2nd of 12, shd behind Top Score (8-9) at Meydan 7f stks gd in Feb.
Grey Britain (8-9) 5th of 12, 3 3/4l behind Top Score (8-9) at Meydan 7f stks gd in Feb.